Search PubMed⌕ Search

Biomedical subjects

J Kasten-Jolly

Publications and source records attributed to J Kasten-Jolly.

25 records · Page 2Linked to original sources
PubMed1985

Heterogeneity in the globin chain composition of a human minor fetal hemoglobin component.

The first hemoglobin found to contain an acetyl blocking group was the minor human fetal hemoglobin, Hb FI, present as 10-15% of the total fetal hemoglobin in umbilical cord blood red cells. Acetylation occurs at the amino-terminal glycine of the gamma-globin chain. Assays for the acetyl group by two different methods gave values less than the 2 per tetramer expected for a fully acetylated hemoglobin. We have purified acetylated fetal hemoglobin FIc to homogeneity. The globin chain composition of Hb FIc has been examined by both globin chain separation on CM-cellulose and by tryptic peptide mapping by HPLC. The identities of the gamma globin chains and of the gamma T-1 peptides were confirmed by amino acid analysis. Globin chain separation profiles showed the presence of 22.3 +/- 7.0% of gamma 0 globin (of the total gamma globin) in Hb FIc. Accordingly, the tryptic peptide maps of Hb FIc tetramers also showed the presence of a similar amount of gamma 0T-1 peptide. The gamma 0T-1 peptide was not present in the maps of isolated gamma Ic globin. It is evident that column purified Hb FIc contains a certain percentage of non-acetylated gamma-globin chains, thus indicating a hybrid globin chain composition for this minor fetal hemoglobin component.

Acetylation↗
PubMed1984

The amino terminal acetylation of cat globin chains and their tryptic peptides.

Cat blood contains two major hemoglobins, HbA and HbB, both of which are synthesized within the same red cell. They contain identical alpha chains but different beta chains. HbB is somewhat unusual in that it contains beta chains that are modified by N alpha-acetylation. Although the selective amino terminal acetylation of the beta chain of cat HbB occurs during nascent peptide chain growth, it can also occur after completion of globin chain synthesis and its assembly into hemoglobin. However, the latter process is not as efficient as the former, and it occurs non-enzymatically. Two peptides in a mixture of tryptic peptides from cat HbA and non-acetylated cat HbB contain serine at their amino terminus. One is the octapeptide, non-acetylated B- beta T-1, and the other is the tetrapeptide, alpha T-2, derived from both HbA and HbB. We provide evidence here that in a mixture of soluble tryptic peptides, acetylation of alpha T-2 takes place in the presence of acetyl-CoA and ribosomal acetyltransferase at pH 7.0. The amino terminal acetylation requires the presence of an acetyltransferase.

Acetyl Coenzyme A↗
PubMed1984

Biosynthesis of cat hemoglobins: translation of poly(A)-RNA from animals of various HbA/HbB phenotypes.

The molecular basis for the genetic control of variable proportions of the two hemoglobins in domestic cat blood was investigated. Both major hemoglobins of cat blood, HbA (alpha 2 beta A2) and HbB (alpha 2 beta B2), were synthesized in an mRNA-dependent rabbit reticulocyte system using poly(A)-RNA from cat reticulocyte polysomes as the source of the message. The relative amounts of HbA and HbB synthesized in the system were a function of the HbA/HbB phenotype of the cat from which the reticulocytes and poly(A)-RNA were obtained. Higher ratios of HbA/HbB synthesis were found when the source of poly(A)-RNA was the polysomes from a 90/10 (HbA/HbB) phenotype than when it was from a 50/50 (HbA/HbB) phenotype. These results indicate that the variable proportions of HbA and HbB found in the blood of different members of the cat population result from the genetic control of the relative amounts of functional beta A and beta B mRNA.

Animals↗
PubMedDate not supplied

Use of allogeneic bone marrow labeled with neomycin resistance gene to examine bone marrow-derived chimerism in experimental organ transplantation.

Posttransplant infusion of viable donor bone marrow cells (DBMC) has been shown in our previous studies to promote acceptance of incompatible kidney allografts in rhesus monkeys after treatment with polyclonal antithymocyte globulin to deplete peripheral T-lymphocytes. In this nonhuman primate model, the infusion of the DBMC is requisite for the induction of functional graft tolerance and specific MLR and CTLp unresponsiveness, although the relevant role and fate of bone marrow-derived chimeric cells is uncertain. Standard immunological and molecular techniques applied to this monkey model are unable to differentiate between chimeric cells derived from the infused DBMC and those derived from allograft-borne passenger leukocyte emigrants. To distinguish chimerism due to infused DBMC, we transduced DBMC with a functional neomycin resistance gene (Neo(r)) using the retroviral vector pHSG-Neo.Neo(r)-transduced BMC were infused into recipients approximately 2 wk after kidney transplantation and treatment with rabbit antithymocyte globulin. No maintenance immunosuppressive drugs were given. Genomic DNA isolated from peripheral blood leukocytes was used to monitor the presence ofNeo(r)-positive cells. Tissue samples obtained at necropsy also were assessed forNeo(r)-positive chimeric cells. The presence of DBMC-derived chimerism was assessed by polymerase chain reaction usingNeo(r) sequence-specific primers (PCR-SSP). Chimerism was detectable in recipient tissues at various times for up to 6 mo after DBMC infusion. These studies using gene transduction methodology indicate that a stable genetic marker can provide capability to examine DBMC-derived chimerism for prolonged periods in a nonhuman primate model. This approach should facilitate future studies in preclinical models to study the role and type of chimeric cell lineages in relation to functional allograft tolerance.

Animals↗